LILRB2 and neoplasm: More importantly, the cytolytic ability of T cells was significantly improved when they were co-cultured with anti-ILT4- or anti-PD-L1- or both antibody-pretreated tumor cells, in which the combination group generated the strongest tumor eradication in response to T cells (Figure 5O).